Q2 2026 Holdings
Filed 2026-08-14 | 92 holdings | $2.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $280.9M | 1,500,000 | 11.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $170.6M | 1,600,000 | 6.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $136.3M | 1,600,000 | 5.4% |
| CVS Health Corp(CVS) | COM | 126650100 | $113.8M | 1,100,000 | 4.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $81.3M | 2,000,000 | 3.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $75.1M | 1,750,000 | 3.0% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $73.4M | 300,000 | 2.9% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $71.3M | 300,000 | 2.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $70.8M | 2,000,000 | 2.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $61.1M | 550,000 | 2.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $56.5M | 625,000 | 2.2% |
| Revolution Medicines Inc(RVMD)Put | COM | 76155X100 | $56.2M | 300,000 | 2.2% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $47.6M | 2,000,000 | 1.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $45.0M | 350,000 | 1.8% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $42.4M | 200,000 | 1.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $41.5M | 900,000 | 1.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $41.3M | 750,000 | 1.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $38.4M | 900,000 | 1.5% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $38.4M | 550,000 | 1.5% |
| Abbott Laboratories(ABT) | COM | 002824100 | $36.3M | 400,000 | 1.4% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $35.3M | 85,000 | 1.4% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $32.1M | 3,000,000 | 1.3% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $31.3M | 200,000 | 1.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $31.3M | 1,000,000 | 1.2% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $30.9M | 165,000 | 1.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $28.9M | 325,000 | 1.1% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $28.8M | 600,000 | 1.1% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $25.9M | 550,000 | 1.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $25.3M | 150,000 | 1.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $24.9M | 40,000 | 1.0% |
| Ionis Pharmaceuticals Inc(IONS)Call | COM | 462222100 | $23.8M | 300,000 | 0.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $21.6M | 100,000 | 0.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $21.3M | 375,000 | 0.8% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $21.1M | 190,000 | 0.8% |
| Glaukos Corp(GKOS) | COM | 377322102 | $21.0M | 150,000 | 0.8% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $20.6M | 1,900,000 | 0.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $20.5M | 275,000 | 0.8% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $19.9M | 40,000 | 0.8% |
| Alumis Inc(ALMS) | COM | 022307102 | $19.7M | 700,000 | 0.8% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $19.3M | 50,000 | 0.8% |
| Centene Corp del(CNC) | COM | 15135B101 | $19.3M | 300,000 | 0.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $18.3M | 1,000,000 | 0.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $18.0M | 15,000 | 0.7% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $16.3M | 200,000 | 0.6% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $15.8M | 600,000 | 0.6% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $15.6M | 200,000 | 0.6% |
| Waters Corp(WAT) | COM | 941848103 | $15.0M | 40,000 | 0.6% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $14.8M | 180,000 | 0.6% |
| Novo-Nordisk A S(NVO)Call | ADR | 670100205 | $14.4M | 300,000 | 0.6% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $14.3M | 675,000 | 0.6% |